Prevalence, predictors, and outcomes of patients with non–ST-segment elevation myocardial infarction and insignificant coronary artery disease: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative
Manesh R. Patel(Duke University), Matthew T. Roe(Clinical Research Institute), Ralph G. Brindis, L. Kristin Newby(Duke University), Charles V. Pollack, Robert A. Harrington(Clinical Research Institute), Eric D. Peterson(The University of Texas Southwestern Medical Center), Anita Y. Chen(University of Rochester Medicine), Jorge F. Saucedo, E. Magnus Ohman(Duke University), W. Brian Gibler(University of Cincinnati), Deepak L. Bhatt(Mount Sinai Hospital), C. Michael Gibson(Baim Institute for Clinical Research), Neal S. Kleiman(Houston Methodist)
Cited by 214
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k